MedWatch

Lundbeck's head of R&D to join board of e-health firm Brain+

The publicly listed firm in Denmark has lured Johan Luthman to the board table, which following an expansion will seat five members instead of three.

Kim Baden-Kristensen, founder and CEO of Brain+ | Photo: Brain+ / PR

Danish e-health firm Brain+ will strengthen its board markedly by electing three life science profiles, one of which is none other than Johan Luthman, Lundbeck’s head of research and development, to the company’s board of directors at an upcoming extraordinary general meeting on Sept. 2, according to a press release.

Three new appointees will join the company’s two existing board members, while Jonas Nielsen, co-founder of healthcare firm Practio, gives up his seat to make room for the new additions.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs